Gemzar Combination Therapy Receives European Regulatory Approvals for Treatment of Ovarian Cancer
Indianapolis (ots/PRNewswire) - Eli Lilly and Company's Gemzar(R) (gemcitabine), approved to treat patients with pancreas, non-small-cell lung, metastatic breast and bladder cancers, receives approvals for a fifth indication. Lilly announced today that regulatory officials in several European markets ...